Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Abrams

Showing results (301-310 of 367) with videos related to

Pageof 37
Sort By:
Advances in Biological Regulation|November 4, 2015
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cellsWilliam H Chappell, Stephen L Abrams, Kvin Lertpiriyapong, et al.
Psychiatry Research|August 5, 2010
Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco DependenceArthur L Brody, Edythe D London, Richard E Olmstead, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2008
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigaretteArthur L Brody, Mark A Mandelkern, Richard E Olmstead, et al.
Oncotarget|October 27, 2012
Effects of ectopic expression of NGAL on doxorubicin sensitivityWilliam H Chappell, Stephen L Abrams, Giuseppe Montalto, et al.
JAMA|May 29, 1972
Radiologic aspects of renovascular hypertension. 2. The role of urography in unilateral renovascular diseaseJ J Bookstein, H L Abrams, R E Buenger, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Advances in Biological Regulation|October 18, 2012
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatmentWilliam H Chappell, Stephen L Abrams, Kristin M Stadelman, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Current Pharmaceutical Design|October 22, 2013
Signaling intermediates (MAPK and PI3K) as therapeutic targets in NSCLCLudovica Ciuffreda, Ursula Cesta Incani, Linda S Steelman, et al.
Pageof 37

Showing results (301-310 of 367) with videos related to

Sort By:
Pageof 37
Advances in Biological Regulation|November 4, 2015
Novel roles of androgen receptor, epidermal growth factor receptor, TP53, regulatory RNAs, NF-kappa-B, chromosomal translocations, neutrophil associated gelatinase, and matrix metalloproteinase-9 in prostate cancer and prostate cancer stem cellsWilliam H Chappell, Stephen L Abrams, Kvin Lertpiriyapong, et al.
Psychiatry Research|August 5, 2010
Smoking-induced change in intrasynaptic dopamine concentration: effect of treatment for Tobacco DependenceArthur L Brody, Edythe D London, Richard E Olmstead, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 20, 2008
Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigaretteArthur L Brody, Mark A Mandelkern, Richard E Olmstead, et al.
Oncotarget|October 27, 2012
Effects of ectopic expression of NGAL on doxorubicin sensitivityWilliam H Chappell, Stephen L Abrams, Giuseppe Montalto, et al.
JAMA|May 29, 1972
Radiologic aspects of renovascular hypertension. 2. The role of urography in unilateral renovascular diseaseJ J Bookstein, H L Abrams, R E Buenger, et al.
Biochimica Et Biophysica Acta|August 18, 2015
Roles of NGAL and MMP-9 in the tumor microenvironment and sensitivity to targeted therapySaverio Candido, Stephen L Abrams, Linda S Steelman, et al.
Advances in Biological Regulation|October 18, 2012
Increased NGAL (Lnc2) expression after chemotherapeutic drug treatmentWilliam H Chappell, Stephen L Abrams, Kristin M Stadelman, et al.
Oncotarget|November 5, 2017
Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cellsStephen L Abrams, Peter P Ruvolo, Vivian R Ruvolo, et al.
Advances in Biological Regulation|June 6, 2017
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseasesJames A McCubrey, Kvin Lertpiriyapong, Linda S Steelman, et al.
Current Pharmaceutical Design|October 22, 2013
Signaling intermediates (MAPK and PI3K) as therapeutic targets in NSCLCLudovica Ciuffreda, Ursula Cesta Incani, Linda S Steelman, et al.
Pageof 37